Figure 1.
Noncoding RNAs in sEVs derived from different tissues/cells mediate the progression of diabetes and its complications. sEV noncoding RNAs derived from plasma/urinary tissue have mainly been explored as biomarkers for diabetes and its complications. sEV noncoding RNAs derived from adipose/pancreatic/skeletal muscle/liver/kidney tissue have been proven to have important roles in insulin secretion and sensitivity regulation, whereas BM-MSCs and umbilical cord-derived sEV noncoding RNAs are promising agents for diabetic therapy.